This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Laboratorio Reig Jofre 미래 성장

Future 기준 확인 4/6

Laboratorio Reig Jofre is forecasted to grow earnings and revenue by 26.6% and 5.5% per annum respectively. EPS is expected to grow by 26.4%. Return on equity is forecast to be 8.5% in 3 years.

주요 정보

26.6%

수익 성장률

26.4%

EPS 성장률

Pharmaceuticals 수익 성장	14.6%
매출 성장률	5.5%
향후 자기자본 수익률	8.5%
애널리스트 커버리지	Low
마지막 업데이트	n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

업데이트 없음

수익 및 매출 성장 예측

BME:RJF.D - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2024	291	14	17	35	1
12/31/2023	279	12	14	31	1
12/31/2022	261	7	4	19	1
12/31/2021	240	5	-5	14	N/A
9/30/2021	237	6	N/A	N/A	N/A
6/30/2021	234	6	9	26	N/A
3/31/2021	234	6	N/A	N/A	N/A
12/31/2020	234	6	7	19	N/A
9/30/2020	229	8	N/A	N/A	N/A
6/30/2020	229	6	-15	14	N/A
3/31/2020	219	6	N/A	N/A	N/A
12/31/2019	206	5	-19	12	N/A
9/30/2019	199	7	N/A	N/A	N/A
6/30/2019	188	9	-10	16	N/A
3/31/2019	188	9	N/A	N/A	N/A
12/31/2018	185	9	-6	15	N/A
9/30/2018	185	10	N/A	N/A	N/A
6/30/2018	179	9	-4	14	N/A
3/31/2018	175	9	N/A	N/A	N/A
12/31/2017	172	9	3	21	N/A
9/30/2017	164	5	N/A	N/A	N/A
6/30/2017	164	7	-6	8	N/A
3/31/2017	164	8	N/A	N/A	N/A
12/31/2016	161	8	-14	-1	N/A
9/30/2016	160	5	N/A	N/A	N/A
6/30/2016	159	5	-4	8	N/A
3/31/2016	156	5	N/A	N/A	N/A
12/31/2015	157	9	2	13	N/A

애널리스트 미래 성장 예측

수입 대 저축률: RJF.D's forecast earnings growth (26.6% per year) is above the savings rate (0.9%).

수익 vs 시장: RJF.D's earnings (26.6% per year) are forecast to grow faster than the Spanish market (10.3% per year).

고성장 수익: RJF.D's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: RJF.D's revenue (5.5% per year) is forecast to grow faster than the Spanish market (3% per year).

고성장 수익: RJF.D's revenue (5.5% per year) is forecast to grow slower than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: RJF.D's Return on Equity is forecast to be low in 3 years time (8.5%).